A groundbreaking AI system, Delphi-2M, predicts disease risks up to 20 years in advance by analyzing extensive medical records from over 40,000 Biobank participants and 1.9 million Danish health records. Developed by a team from the German Cancer Research Center, the University of Copenhagen, and the European Molecular Biology Laboratory, this innovative tool forecasts the progression of over 1,000 diseases, including type 2 diabetes and heart attacks. Published in Nature, the AI’s ability to identify high-risk individuals allows for early interventions, promoting better health outcomes. Its transformer-based model excels in predicting and understanding personalized health risks, serving as a powerful asset for precision medicine. While acknowledging AI’s environmental challenges, researchers emphasize its potential in addressing pressing global issues. Future tests for Delphi-2M will expand across diverse populations, aiming for clinical application soon. The findings offer hope for lifestyle modifications to combat disease progression. Stay updated with innovations reshaping our future!
Source link
